TAG:
clinical laboratory testing
Pick Your Medicine: Personalized or Precision?
By R. Lewis Dark | From the Volume XIX No. 2 – January 30, 2012 Issue
DURING THE PERSONALIZED MEDICINE WORLD CONFERENCE (PMWC) that took place in Silicon Valley last week, there was much excitement about the earliest clinical services that meet the definition of personalized medicine. It won’t surprise pathologists and lab administrators to learn that companion diag…
Personalized Medicine: Meet Pathologists’ New Competitors
By Robert Michel | From the Volume XIX No. 2 – January 30, 2012 Issue
IF THERE IS ANY SINGLE “NEXT BIG THING†that will truly revolutionize healthcare, it is likely to be personalized medicine. This approach promises to deliver improved outcomes to individual patients, while helping to control—or even reduce—the cost of care. Central to personalized medicine w…
January 30, 2012 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XIX No. 2 – January 30, 2012 Issue
It’s a sign of the times and a warning to clinical labs and lab industry vendors. Money is short at some community hospitals— meaning bills are going unpaid. In Birmingham, Alabama, the Birmingham News reported that Cooper Green Mercy Hospital is $1 million behind in its…
2011’s Top 10 Lab Stories Point to a Busy 2012
By Robert Michel | From the Volume XIX No. 1 – January 9, 2012 Issue
CEO SUMMARY: Given the specific news stories that make up THE DARK REPORT’S list of the “Top Ten Lab Stories for 2011,†it might be said that 2011 was a rather quiet year overshadowed by anticipation of the coming reforms mandated by the Accountable Care Act of 2010. For the clinica…
Why Capitate Genetic and Molecular Test Prices?
By R. Lewis Dark | From the Volume XVIII No. 17 – December 19, 2011 Issue
HOW MANY OF YOU LIVED THROUGH THE DECADE OF THE 1990s and experienced the free fall in the prices managed care plans paid for clinical laboratory testing? In California—at the peak of this insanity—some lab companies offered full risk, capitated contracts for as low as 20¢ PMPM (per member per m…
LabCorp’s BeaconLBS Aims To Manage Genetic Tests
By Joseph Burns | From the Volume XVIII No. 17 – December 19, 2011 Issue
CEO SUMMARY: BeaconLBS is a new business created by Laboratory Corporation of America. It says it wants to help health insurance plans manage molecular diagnostics and genetic testing. BeaconLBS is now recruiting other clinical labs to join its network and is meeting with payers to offer …
Economics of Lab Testing to Be Challenged
By R. Lewis Dark | From the Volume XVIII No. 15 – November 7, 2011 Issue
BY ANY MEASURE, 2012 IS SHAPING UP TO BE A YEAR OF MAJOR CHANGE for healthcare and the clinical laboratory testing industry. Unfortunately, an early reading of the tea leaves indicates that the outcomes are not likely to be favorable for most clinical laboratories and anatomic pathology groups. Letâ…
Lab Testing, Pathology Is Fast-Growing in China
By Robert Michel | From the Volume XVIII No. 15 – November 7, 2011 Issue
CEO SUMMARY: It was record attendance at the major pathology congress which took place in Hangzhou, China, last month. Because of the ongoing growth of China’s economy, the demand for healthcare—and for high-quality clinical lab and pathology testing—is rising at an accelerated pace…
September 26, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 13 – September 26, 2011 Issue
Here’s a laboratory with what may be one of the world’s biggest accounts receivable problems. In South Africa, the National Health Laboratory Services (NHLS) says it is owed $1.8 billion Rand (about US $214 million) from its client accounts. As reported by a regional television s…
Quest Diagnostics and LabCorp Report Second Quarter Earnings
By Robert Michel | From the Volume XVIII No. 10 – July 25, 2011 Issue
JUST ONE DAY APART, the nation’s two largest laboratory testing companies reported second quarter and half-year earnings for 2011. Each financial report opened a window into marketplace developments for the first six months of this year. First to release its earnings report was Quest Diagn…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized